President Pushes Gold Standard Childhood Vaccine Recommendations Nationwide
Published Date: 8/14/2026
Presidential Document
Summary
No summary available.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Federal 'Gold Standard' Vaccine List
The Order declares a set of "Gold Standard Childhood Vaccine Recommendations" and explicitly lists vaccines in three categories: (i) recommended for all children — measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella; (ii) recommended for certain high-risk groups — RSV monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, and dengue; and (iii) based on shared clinical decision-making — hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19.
Option for Single‑Antigen MMR and Separate Visits
The Order directs HHS to present plans within 90 days to offer options to administer core childhood vaccines, starting with MMR, as single‑disease shots (the Order says MMR should be given in three separate single‑disease shots once such products are domestically available) and, to the maximum extent feasible, to administer childhood immunizations at separate medical visits while guaranteeing continued availability of combination vaccines.
Federal Legal Support for Parental Exemptions
The Order directs the Attorney General to take appropriate measures to further meritorious legal actions challenging State laws that conflict with constitutional and Federal statutory obligations related to parental authority, religious freedom, disability accommodations, and equal protection, including, where applicable under Federal law, States' obligations to provide religious and medical exemptions from childhood and adolescent immunization requirements; Departments of Justice, Education, and HHS must also act to ensure their contractors and grantees comply with those obligations.
Vaccine Safety Research and Monitoring Boost
The HHS Task Force must, within 90 days, present plans to develop additional alternative adjuvants to aluminum, conduct comparative safety and efficacy studies, ensure continuous evaluation of risk/benefit profiles using U.S. and international data, and improve vaccine safety monitoring, transparency, and research.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16748, Continuation of the National Emergency With Respect to Export Control Regulations
2026-16589, Paperwork Reduction Act; Proposed Collection; Comment Request; Revisions of Currently Approved Collection: Drug-Free Communities (DFC) Support Program and Community-Based Coalition Enhancement Grants To Address Local Drug Crisis (CARA) Local Drug Crisis Program National Evaluation
In accordance with the Paperwork Reduction Act of 1995, the Office of National Drug Control Policy (ONDCP) announces it will submit to the Office of Management and Budget (OMB) Office of Information and Regulatory Affairs (OIRA) an information collection request.
2026-16403, Continuing To Protect the Meaning and Value of American Citizenship
2026-16404, Ending Birth Tourism
2026-16401, National Purple Heart Day, 2026
2026-16400, Adjusting Imports of Polysilicon and Its Derivatives Into the United States